Home Monitoring Device for COPD Exacerbations
Early Detection of COPD Exacerbations Using Home Monitoring Device
Recruiting
Observational Study
COPD Exacerbation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- RespirAI US Inc · Industry
Who this trial is looking for
This trial is looking for adults over 21 with diagnosed COPD who have had recent flare-ups. Participants will use a home monitoring device to help detect worsening symptoms early.
Are You a Good Fit for This Trial?
You may be able to join if
- I am over 21 years old.
- I have been diagnosed with COPD at least 6 months ago.
- I have had two or more moderate COPD flare-ups in the past 6 months.
- I have had one severe COPD flare-up in the past 6 months.
- I have been free of flare-ups for the past month.
You may not be able to join if
- I cannot or will not sign the informed consent.
- I cannot complete the 6-minute walk test due to health issues.
- I have a pacemaker or other implanted electronic device.
- I am pregnant.
- The study team believes I cannot follow all study procedures.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The de…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>21 years.
* Physician-diagnosed COPD at least 6 months prior to screening visit.
* Two or more moderate COPD exacerbations in the past 6 months or 1 severe exacerbation during the past 6 months.
* Free of exacerbation for 1 month before enrollment.
Exclusion Criteria:
…
Contacts